Results 171 to 180 of about 10,949 (215)
Some of the next articles are maybe not open access.
Neurology, 1998
Mortality and morbidity associated with status epilepticus (SE) are, to a large extent, determined by the etiology underlying SE and the rapidity with which seizures are controlled.1 Most patients with SE will respond to aggressive treatment protocols that include repeated high doses of phenytoin, phenobarbital, and benzodiazepine.
R D, Sheth, B E, Gidal
openaire +2 more sources
Mortality and morbidity associated with status epilepticus (SE) are, to a large extent, determined by the etiology underlying SE and the rapidity with which seizures are controlled.1 Most patients with SE will respond to aggressive treatment protocols that include repeated high doses of phenytoin, phenobarbital, and benzodiazepine.
R D, Sheth, B E, Gidal
openaire +2 more sources
Hypothermia for Refractory Status Epilepticus
Neurocritical Care, 2008Status epilepticus (SE) can be refractory to conventional anticonvulsants, requiring anesthetic doses of medications to suppress seizures. This approach carries significant morbidity, is associated with a high fatality rate, and may not always control SE.
Jesse J, Corry +3 more
openaire +2 more sources
Super-Refractory Status Epilepticus
Current Neurology and Neuroscience Reports, 2015Although the vast majority of patients with status epilepticus (SE) respond fairly well to the first- or second-line anti-epileptics, a minority require anesthetic agents to put the seizures under control. An even smaller number of patients do not even respond to those and constitute the subgroup of super-refractory SE.
Mauricio Ruiz, Cuero +1 more
openaire +2 more sources
Neurology India, 2006
Refractory status epilepticus (RSE) is a common problem in intensive care units and emergency departments. The important risk factor predisposing patients with SE to RSE is delay in receiving treatment. Self-sustaining SE is associated with progressive, time-dependent development of pharmacoresistance.
openaire +2 more sources
Refractory status epilepticus (RSE) is a common problem in intensive care units and emergency departments. The important risk factor predisposing patients with SE to RSE is delay in receiving treatment. Self-sustaining SE is associated with progressive, time-dependent development of pharmacoresistance.
openaire +2 more sources
VNS for refractory status epilepticus
Epilepsy Research, 2015Our goal was to perform a systematic review of the literature on the insertion of vagal nerve stimulators (VNS) for refractory status epilepticus (RSE) and its impact on the control of RSE.All articles from MEDLINE, BIOSIS, EMBASE, Global Health, HealthStar, Scopus, Cochrane Library, the International Clinical Trials Registry Platform, clinicaltrials ...
F.A. Zeiler +4 more
openaire +2 more sources
Current Opinion in Critical Care, 2005
Although conventional anticonvulsant agents can terminate status epilepticus in most cases, a substantial minority of patients develops medically refractory status and requires more aggressive care. This review explores the options available.Increasing numbers of previously unexpected etiologies for refractory status epilepticus continue to be reported.
openaire +2 more sources
Although conventional anticonvulsant agents can terminate status epilepticus in most cases, a substantial minority of patients develops medically refractory status and requires more aggressive care. This review explores the options available.Increasing numbers of previously unexpected etiologies for refractory status epilepticus continue to be reported.
openaire +2 more sources
Neuromodulation in Super-refractory Status Epilepticus
Journal of Clinical Neurophysiology, 2021Summary: Status epilepticus (SE) is a severe condition that needs immediate pharmacological treatment to tackle brain damage and related side effects. In approximately 20% of cases, the standard treatment for SE does not control seizures, and the condition evolves to refractory SE.
Ioannis, Stavropoulos +2 more
openaire +2 more sources
Isoflurane for Refractory Status Epilepticus
Anesthesiology, 1989General anesthesia has been recommended to control convulsive status epilepticus that is refractory to conventional anticonvulsant therapy. Halothane has been the recommended agent, but without experimental justification. Isoflurane, which has no reported organ toxicity and produces electrographic suppression at clinically useful concentrations in ...
Kofke, W. A. +12 more
openaire +5 more sources
Role of Propofol in Refractory Status Epilepticus
Annals of Pharmacotherapy, 1998OBJECTIVE: To provide a review of the proposed mechanism of action, clinical efficacy, adverse effects, and therapeutic considerations associated with the use of propofol in the management of patients with refractory status epilepticus. DATA SOURCES:
L A, Brown, G M, Levin
openaire +2 more sources
Electroencephalographic Reporting for Refractory Status Epilepticus
Journal of Clinical Neurophysiology, 2019Purpose: We aimed to determine whether clinical EEG reports obtained from children in the intensive care unit with refractory status epilepticus could provide data for comparative effectiveness research studies. Methods: We conducted a retrospective descriptive study to assess the ...
Arnold J, Sansevere +24 more
openaire +2 more sources